Mr. Muiris O'Connor:

We do not have a full position. We have a working position that we bring to the working group. This is where we push for resolution of the discussions and a settling down to something that industry can work with. We are considered to have a good understanding of the industry perspective. There are quite pragmatic difficulties with some of the recommendations of the Commission. The pharmaceutical industry tells us a simultaneous launch in 27 markets is very difficult. There could be quite superficial moves in this direction, whereby something is nominally launched but the price point is-----